Cart
sales@molnova.com
Dehydroabiethylamine
CAS No. 1446-61-3
Dehydroabiethylamine( Leelamine | Leelamine free base | NSC-2955 | NSC 2955 | NSC2955 )
Catalog No. M27157 CAS No. 1446-61-3
Dehydroabiethylamine is an inducer of hepatic CYP2B activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 31 | In Stock |
|
Biological Information
-
Product NameDehydroabiethylamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroabiethylamine is an inducer of hepatic CYP2B activity.
-
DescriptionDehydroabiethylamine is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
SynonymsLeelamine | Leelamine free base | NSC-2955 | NSC 2955 | NSC2955
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1446-61-3
-
Formula Weight285.475
-
Molecular FormulaC20H31N
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (350.30 mM)
-
SMILESCC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Okolotowicz KJ, et al. Selective benzimidazole inhibitors of the antigen receptor-mediated NF-kappaB activationpathway. Bioorg Med Chem. 2010 Mar 1;18(5):1918-24.
molnova catalog
related products
-
Guan-fu base A
Guanfu base A is a potent noncompetitive CYP2D6 inhibitor (Ki: 1.20 μM in HLMs; Ki: 0.37 μM for rCYP2D6). It also inhibits HERG channel current.
-
Antihistamine-1
Antihistamine-1 is an H1-antihistamine (Ki: 6.9 nM) with acceptable blood-brain barrier penetration and also an inhibitor of CYP2D6 and hERG channel (IC50s: 5.4 and 0.8 μM).
-
Verapamil
Verapamil is a calcium channel blocker and an orally active and effective inhibitor of P-gp.
